Psilocybin and Burnout: What the Research Has Looked At

You keep running, and the tank doesn't refill. Weekends and holidays help for a day or two, then the same flatness comes back. Some people call it burnout; many high performers resist the word. This article looks at what burnout is, how it differs from feeling stuck, and what psilocybin research has and hasn't shown.

What is burnout?

Burnout is a response to long-term work stress that builds gradually and can become chronic. It shows up as exhaustion that rest doesn't fix, growing distance or cynicism about work, and a sense that your effort no longer makes a difference. Researchers describe it as one of the most significant psychological hazards for working professionals.

A review of burnout research describes it as "an individual response to chronic work stress that develops progressively and can eventually become chronic." It affects how people think, feel and behave, toward their work, their colleagues and their own role.

Is it burnout, or is it feeling stuck?

The two overlap, but they differ in where they come from. Burnout usually follows long stretches of heavy, complex pressure without clear solutions: the tank is empty. Feeling stuck builds more quietly, often when life looks fine from the outside: the tank is full, but there is no clear direction.

The difference matters because the next step differs. Burnout often calls for stepping back from the pressure and recovering first. Feeling stuck may respond to a change of perspective, new challenges or small experiments. Many people, especially in midlife, recognize something of both. If that sounds familiar, our article on feeling stuck in midlife goes further.

What happens in the brain?

Brain imaging studies of people with burnout show weaker coordination between the networks that handle self-reflection and those that handle reward and emotion. One network in particular, the default mode network, is linked to rumination. When it stays overactive under constant stress, thinking can narrow into the same loops.

That narrowing is what many people describe as not being able to switch off: the same worries replaying, and difficulty imagining a different way of working or living.

What does research say about psilocybin and burnout?

Direct research on psilocybin and burnout is still limited. A small randomized trial with frontline clinicians during the pandemic found reductions in depression symptoms. Imaging research shows psilocybin makes brain networks less rigid during a session, with some changes measurable weeks later. These findings are promising but early.

A survey of people using psilocybin on their own reported lower burnout and anxiety scores and more flexible thinking afterward. Surveys like this can't show cause and effect, and burnout and depression are different things: you can have one without the other.

Scientists have described a "neuroplastic window" after psilocybin: a period when the brain may be more open to new ways of seeing a problem. That window is one reason the weeks after a session matter.

Clinical trials are studying psilocybin for conditions such as depression. A large 2022 trial in treatment-resistant depression found reduced depression scores after a single session, though side effects were common and results after three months were mixed. A 2024 review of trials concluded psilocybin shows promise for depression. That research takes place in clinical settings, and a retreat is not a treatment.

Why does integration matter for recovery?

Recovery from long-term exhaustion can take months, sometimes years, and a single experience doesn't do the work on its own. The weeks after a session are when people turn what came up into changes they can keep: different boundaries, different routines, different decisions about work. That process is called integration.

Practices that help include journaling, meditation, time in nature, movement, and talking it through with others who understand. Research on mindfulness-based approaches shows they can reduce emotional exhaustion in their own right.

What else helps?

If the tank is empty, the first step is usually creating distance from the pressure: time off, help with the hardest problems, support from a professional. If the tank is full but directionless, curiosity tends to help more: a new project, a conversation with a mentor, small changes to test what matters to you now.

Either way, the aim is the same: to stop repeating the pattern that led here.

How Beckley works with professionals

Many Beckley guests are senior professionals who have been running hard for years. Co-founder Neil Markey has said that 60% of Beckley guests report some form of burnout: "Our programs offer an opportunity to reset, learn new habits, and find relief." Every guest starts with screening and a suitability consultation. Preparation runs online for four weeks, then two guided sessions on retreat with at least one facilitator for every four guests, then six weeks of integration support. See our page on the psilocybin retreat for professionals for how the program fits a working life.

Frequently Asked Questions

Sources

1. Back AL, Freeman-Young TK, Morgan L, et al. Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2024;7(12):e2449026. doi:10.1001/jamanetworkopen.2024.49026
2. Edú-Valsania S, Laguía A, Moriano JA. Burnout: A Review of Theory and Measurement. Int J Environ Res Public Health. 2022 Feb 4;19(3):1780. doi: 10.3390/ijerph19031780. PMID: 35162802; PMCID: PMC8834764.
3. Liu JP, Gu SY, Song CM, Yang HC, Shi Y, Gu YF, Wang SF, Chen YZ. Abnormal intrinsic functional hubs and connectivity in nurses with occupational burnout: a resting-state fMRI study. Front Public Health. 2025 Jun 16;13:1595550. doi: 10.3389/fpubh.2025.1595550. PMID: 40589802; PMCID: PMC12206858.
4. Guan, S., Takahashi, T., Tomita, N. et al. The chain mediation effect of rumination and worry between the intentionality and content dimensions of mind wandering and internalizing symptoms of depression and anxiety. Sci Rep 15, 21223 (2025). https://doi.org/10.1038/s41598-025-99249-5
5. Menon V. 20 years of the default mode network: A review and synthesis. Neuron. 2023 Aug 16;111(16):2469-2487. doi: 10.1016/j.neuron.2023.04.023. Epub 2023 May 10. PMID: 37167968; PMCID: PMC10524518.
6. Quitkin FM, McGrath PJ, Stewart JW, Deliyannides D, Taylor BP, Davies CA, Klein DF. Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients. J Clin Psychiatry. 2005 Jun;66(6):670-6. doi: 10.4088/jcp.v66n0601. PMID: 15960558.
7. Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443. PMID: 36322843.
8. Fang S, Yang X, Zhang W. Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials. Front Psychiatry. 2024 Feb 15;15:1359088. doi: 10.3389/fpsyt.2024.1359088. PMID: 38426002; PMCID: PMC10902050.
9. Laabi S, LeMmon C, Vogel C, Chacon M, Jimenez VM Jr. Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling. Int Immunopharmacol. 2025 Jun 26;159:114940. doi: 10.1016/j.intimp.2025.114940. Epub 2025 May 26. PMID: 40424654.
10. Siegel, J.S., Subramanian, S., Perry, D. et al. Psilocybin desynchronizes the human brain. Nature 632, 131–138 (2024). https://doi.org/10.1038/s41586-024-07624-5
11. Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Front Psychiatry. 2023 Sep 19;14:1199642. doi: 10.3389/fpsyt.2023.1199642. PMID: 37795509; PMCID: PMC10545967.
12. Karlson, B., Jönsson, P. & Österberg, K. Long-term stability of return to work after a workplace-oriented intervention for patients on sick leave for burnout. BMC Public Health 14, 821 (2014). https://doi.org/10.1186/1471-2458-14-821
13. Bathje GJ, Majeski E, Kudowor M. Psychedelic integration: An analysis of the concept and its practice. Front Psychol. 2022 Aug 4;13:824077. doi: 10.3389/fpsyg.2022.824077. PMID: 35992410; PMCID: PMC9386447.
14. Müller, M., & Kubátová, J. (2026). A systematic review of managerial burnout and personal crisis: Navigating the interplay of individual, organizational, and environmental factors. German Journal of Human Resource Management: Zeitschrift Für Personalforschung, 40(1), 15-55.
15. Ng, K., & Yang, W.-N. (2024). Feeling stuck and feeling bad: Career plateaus, negative emotions, and counterproductive work behaviors. Human Resource Management Journal, 34(4), 921–941.
16. Dou J, Lian Y, Lin L, Asmuri SNB, Wang P, Rajen Durai RA. Effectiveness of mindfulness-based interventions on burnout, resilience and sleep quality among nurses: a systematic review and meta-analysis of randomized controlled trials. BMC Nurs. 2025 Jul 1;24(1):739. doi: 10.1186/s12912-025-03101-0. PMID: 40598019; PMCID: PMC12210539.
17. Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl). 2018 Feb;235(2):399-408. doi: 10.1007/s00213-017-4771-x. Epub 2017 Nov 8. PMID: 29119217; PMCID: PMC5813086.
18. Roberts BF, Zylko AL, Waters CE, Crowder JD, Gibbons WJ Jr, Sen AK, Jones JA, McMurray MS. Effect of psilocybin on decision-making and motivation in the healthy rat. Behav Brain Res. 2023 Feb 25;440:114262. doi: 10.1016/j.bbr.2022.114262. Epub 2022 Dec 15. PMID: 36529299.
19. Luisa Prochazkova, Josephine Marschall, Michiel van Elk, Ben D. Rifkin, Neil R. Schon, Donatella Fiacchino, George Fejer, Martin Kuchar, Bernhard Hommel, Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials, Neuropharmacology, Volume 284, 2026, 110732, ISSN 0028-3908

Sources

1. shown (jamanetwork.com). https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2827553
2. one study (pmc.ncbi.nlm.nih.gov). https://pmc.ncbi.nlm.nih.gov/articles/PMC8834764/
3. negative feedback loop (nature.com). https://www.nature.com/articles/s41598-025-99249-5
4. stuck (pmc.ncbi.nlm.nih.gov). https://pmc.ncbi.nlm.nih.gov/articles/PMC3191246/
5. Default Mode Network (sciencedirect.com). https://www.sciencedirect.com/science/article/pii/S0896627323003082
6. Some studies (pubmed.ncbi.nlm.nih.gov). https://pubmed.ncbi.nlm.nih.gov/15960558/
7. landmark 2022 paper (pubmed.ncbi.nlm.nih.gov). https://pubmed.ncbi.nlm.nih.gov/36322843/
8. said (pubmed.ncbi.nlm.nih.gov). https://pubmed.ncbi.nlm.nih.gov/38426002/
9. argued (sciencedirect.com). https://www.sciencedirect.com/science/article/abs/pii/S1567576925009300
10. published (nature.com). https://www.nature.com/articles/s41586-024-07624-5
11. study (pmc.ncbi.nlm.nih.gov). https://pmc.ncbi.nlm.nih.gov/articles/PMC10545967/
12. months to years (link.springer.com). https://link.springer.com/article/10.1186/1471-2458-14-821
13. Integration (pmc.ncbi.nlm.nih.gov). https://pmc.ncbi.nlm.nih.gov/articles/PMC9386447/